Kenny Frazier

Kenny Frazier has a diverse and extensive work experience in the pharmaceutical industry. Kenny started their career in 1996 with DuPont Pharmaceuticals and later joined DuPont-Merck-DuPont Pharma-BMS as a Director of Clinical Operations. In 2001, they became the Director of Clinical Operations at Tanox, Inc. and then moved on to Lexicon Pharmaceuticals as the Senior Director of Clinical Operations in 2005. From 2013 to 2015, they served as the Vice President of Clinical Development and Regulatory Affairs at Opexa Therapeutics. Following that, they worked at Savara Pharmaceuticals as the Vice President of Clinical Development. In 2017, they joined Galderma as the Head of Global Clinical Development and later became the Head of Global Prescription Development at Galderma Laboratories, L.P. in 2019.

Kenny Frazier attended Texas Tech University where they studied Biology/Biological Sciences, General.